BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26278647)

  • 1. Non-invasive, serum DNA pregnancy testing leading to incidental discovery of cancer: a good thing?
    Prasad V
    Eur J Cancer; 2015 Nov; 51(16):2272-4. PubMed ID: 26278647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing.
    Amant F; Verheecke M; Wlodarska I; Dehaspe L; Brady P; Brison N; Van Den Bogaert K; Dierickx D; Vandecaveye V; Tousseyn T; Moerman P; Vanderstichele A; Vergote I; Neven P; Berteloot P; Putseys K; Danneels L; Vandenberghe P; Legius E; Vermeesch JR
    JAMA Oncol; 2015 Sep; 1(6):814-9. PubMed ID: 26355862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
    Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service.
    Lau TK; Jiang FM; Stevenson RJ; Lo TK; Chan LW; Chan MK; Lo PS; Wang W; Zhang HY; Chen F; Choy KW
    Prenat Diagn; 2013 Jun; 33(6):602-8. PubMed ID: 23553438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidental detection of maternal malignancy in non-invasive prenatal test].
    Saes L; Govaerts LCP; Knapen MFCM; Lugtenburg PJ; Boere IA; Galjaard RH
    Ned Tijdschr Geneeskd; 2019 Jan; 163():. PubMed ID: 30698367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has noninvasive fetal trisomy testing (NIFTY) rung the death knell for other forms of prenatal testing?
    Parikh FR; Panpalia M; Khandeparkar M
    Fertil Steril; 2014 Jul; 102(1):34-5. PubMed ID: 24890273
    [No Abstract]   [Full Text] [Related]  

  • 8. [Non invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing. Initial experience in Mexican women and literature review].
    Hernández-Gómez M; Ramirez-Arroyo E; Meléndez-Hernández R; Garduño-Zaraza LM; Mayén-Molina DG
    Ginecol Obstet Mex; 2015 May; 83(5):277-88. PubMed ID: 26233973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal testing can detect occult cancer in pregnant women.
    Tanday S
    Lancet Oncol; 2015 Aug; 16(8):e383. PubMed ID: 26190750
    [No Abstract]   [Full Text] [Related]  

  • 11. Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia.
    Hui L; Hyett J
    Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):416-24. PubMed ID: 23902297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. For your interest? The ethical acceptability of using non-invasive prenatal testing to test 'purely for information'.
    Deans Z; Clarke AJ; Newson AJ
    Bioethics; 2015 Jan; 29(1):19-25. PubMed ID: 25521970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis.
    Wright CF; Burton H
    Hum Reprod Update; 2009; 15(1):139-51. PubMed ID: 18945714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: advances in non-invasive prenatal diagnosis.
    Vaiopoulos AG; Athanasoula KC; Papantoniou N; Kolialexi A
    In Vivo; 2013; 27(2):165-70. PubMed ID: 23422474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
    O'Leary P; Maxwell S; Murch A; Hendrie D
    Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliable noninvasive prenatal testing by massively parallel sequencing of circulating cell-free DNA from maternal plasma processed up to 24h after venipuncture.
    Buysse K; Beulen L; Gomes I; Gilissen C; Keesmaat C; Janssen IM; Derks-Willemen JJ; de Ligt J; Feenstra I; Bekker MN; van Vugt JM; Geurts van Kessel A; Vissers LE; Faas BH
    Clin Biochem; 2013 Dec; 46(18):1783-6. PubMed ID: 23933476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free fetal nucleic acid testing: a review of the technology and its applications.
    Sayres LC; Cho MK
    Obstet Gynecol Surv; 2011 Jul; 66(7):431-42. PubMed ID: 21944155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' perspectives on prenatal screening results that suggest maternal cancer: A qualitative analysis.
    Turriff A; Miner SA; Annunziata CM; Bianchi DW
    Prenat Diagn; 2023 Aug; 43(9):1101-1109. PubMed ID: 37409892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.